Jefferies Initiates Coverage On Haemonetics with Buy Rating, Announces Price Target of $150

Benzinga · 1d ago
Jefferies analyst Young Li initiates coverage on Haemonetics (NYSE:HAE) with a Buy rating and announces Price Target of $150.